SPDR S&P Biotech ETF (XBI) option IV low into ASCO 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) 30-day option implied volatility at 28; compared to its 52-week range of 28 to 57 into ACSCO 2023.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eaton (ETN) spreaders of November 6 weekly 397.50, November 6 weekly 440, November 420 and November 470 calls as share price down 7%
- Groupon (GRPN) spreaders of November 22, December 22, January 20 calls
- MSG Rangers, Huron Consulting to join S&P SmallCap 600
Create E-mail Alert Related Categories
OptionsRelated Entities
Standard & Poor's, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
